Asia Executives On The Move: BMS, Pfizer, Takeda, RDPAC

 
• By Brian Yang

Rapid changes in China prompt many pharma companies to shuffle strategies and accelerate personal changes. BMS is getting a new country GM, Pfizer Biopharma China GM is departing and Takeda BU head is stepping down.

Shanghai overpass
MULTINATIONAL DRUG MAKERS SEE MORE EXECUTIVES CHANGES IN CHINA • Source: Shutterstock

More from Business

More from Scrip